Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT: HIPEC + FLOT vs FLOT in Gastric Cancer
NCT04447352Phase 3Recruiting
- Sponsor
- Krankenhaus Nordwest
- Start
- Dec 2020
- Primary completion
- Nov 2026
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132) in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Krankenhaus Nordwest. Started Dec 2020; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT04447352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447352.